Special Issue "Pediatric and Adolescent Psychiatry and Psychology: Current Treatments and Future Options"

A special issue of Clinics and Practice (ISSN 2039-7283).

Deadline for manuscript submissions: 20 April 2024 | Viewed by 826

Special Issue Editor

Dr. Vassilis Martiadis
E-Mail Website
Guest Editor
Department of Mental Health, Community Mental Health Center DS 25, ASL Napoli 1 Centro, Naples, Italy
Interests: mental health; psychiatry; psychopharmacology; depression; schizophrenia; bipolar disorder; psychology

Special Issue Information

Dear Colleagues,

Child and adolescent mental health is a topical issue for society and for clinicians in both the psychiatry and psychology fields. Mental health problems, psychological distress, anxiety, depression and eating disorders have risen consistently after the pandemic, while severe mental diseases such as schizophrenia and bipolar disorder are constantly a matter of concern. Increasing and precocious use of substances further complicates the picture. Therefore, there is an increasing need for evidence-based treatments for child and adolescent mental health-related problems and mental diseases. The aim of this Special Issue is to share novel and evidence-based knowledge on pharmacological and psychological treatments for psychiatric disorders in pediatric and adolescent populations, taking into account both established treatments and future therapeutic options. Original Research, Reviews and Meta-analyses aiming to share clinical and practical knowledge on pharmacotherapies and/or psychotherapies for children and adolescents are welcome and will be peer-reviewed in a timely manner.

Dr. Vassilis Martiadis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Clinics and Practice is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • psychiatry
  • adolescent
  • child
  • treatment
  • psychology
  • mental health
  • psychopharmacology
  • psychotherapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


13 pages, 897 KiB  
Serum Markers of Brain Injury in Pediatric Patients with Congenital Heart Defects Undergoing Cardiac Surgery: Diagnostic and Prognostic Role
Clin. Pract. 2023, 13(5), 1253-1265; https://doi.org/10.3390/clinpract13050113 - 23 Oct 2023
Viewed by 664
Introduction: The objectives of this study were to assess the role of neuromarkers like glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), protein S100 (pS100), and neuron-specific enolase (NSE) as diagnostic markers of acute brain injury and also as prognostic markers [...] Read more.
Introduction: The objectives of this study were to assess the role of neuromarkers like glial fibrillary acidic protein (GFAP), brain-derived neurotrophic factor (BDNF), protein S100 (pS100), and neuron-specific enolase (NSE) as diagnostic markers of acute brain injury and also as prognostic markers for short-term neurodevelopmental impairment. Methods: Pediatric patients with congenital heart defects (CHDs) undergoing elective cardiac surgery were included. Neurodevelopmental functioning was assessed preoperatively and 4–6 months postoperatively using the Denver Developmental Screening Test II. Blood samples were collected preoperatively and postoperatively. During surgery, regional cerebral tissue oxygen saturation was monitored using near-infrared spectroscopy (NIRS). Results: Forty-two patients were enrolled and dichotomized into cyanotic and non-cyanotic groups based on peripheric oxygen saturation. Nineteen patients (65.5%) had abnormal developmental scores in the non-cyanotic group and eleven (84.6%) in the cyanotic group. A good diagnostic model was observed between NIRS values and GFAP in the cyanotic CHD group (AUC = 0.7). A good predicting model was observed with GFAP and developmental scores in the cyanotic CHD group (AUC = 0.667). A correlation was found between NSE and developmental quotient scores (r = 0.09, p = 0.046). Conclusions: From all four neuromarkers studied, only GFAP was demonstrated to be a good diagnostic and prognostic factor in cyanotic CHD patients. NSE had only prognostic value. Full article
Show Figures

Figure 1

Back to TopTop